These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28689692)

  • 1. Patient and Provider Factors Affecting Clinical Inertia in Patients With Type 2 Diabetes on Metformin Monotherapy.
    Mahabaleshwarkar R; Gohs F; Mulder H; Wilkins N; DeSantis A; Anderson WE; Ejzykowicz F; Rajpathak S; Norton HJ
    Clin Ther; 2017 Aug; 39(8):1658-1670.e6. PubMed ID: 28689692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with clinical inertia in type 2 diabetes mellitus patients treated with metformin monotherapy.
    Kartoun U; Iglay K; Shankar RR; Beam A; Radican L; Chatterjee A; Pai JK; Shaw S
    Curr Med Res Opin; 2019 Dec; 35(12):2063-2070. PubMed ID: 31337263
    [No Abstract]   [Full Text] [Related]  

  • 3. Distance to glycemic goal at the time of treatment intensification in patients with type 2 diabetes mellitus failing metformin monotherapy in the United States.
    Fernandes G; Sawhney B; Hannachi H; Liu J; Wang T; Fu AZ; Iglay K; McNeill A; Rajpathak S
    Curr Med Res Opin; 2020 May; 36(5):741-748. PubMed ID: 31990206
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of Add-on Treatment to Metformin Monotherapy for Patients with Type 2 Diabetes and Suboptimal Glycemic Control: A U.S. Database Study.
    Yu S; Schwab P; Bian B; Radican L; Tunceli K
    J Manag Care Spec Pharm; 2016 Mar; 22(3):272-80. PubMed ID: 27003557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care.
    Mata-Cases M; Benito-Badorrey B; Roura-Olmeda P; Franch-Nadal J; Pepió-Vilaubí JM; Saez M; Coll-de-Tuero G;
    Curr Med Res Opin; 2013 Nov; 29(11):1495-502. PubMed ID: 23944631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of time to treatment intensification on glycemic goal attainment among patients with type 2 diabetes failing metformin monotherapy.
    Rajpathak SN; Rajgopalan S; Engel SS
    J Diabetes Complications; 2014; 28(6):831-5. PubMed ID: 25104238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment intensification for patients with type 2 diabetes and poor glycaemic control.
    Fu AZ; Sheehan JJ
    Diabetes Obes Metab; 2016 Sep; 18(9):892-8. PubMed ID: 27160505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Patterns in Patients With Newly Diagnosed Type 2 Diabetes in China: A Retrospective, Longitudinal Database Study.
    Wang C; Gao Y; Zhu L; Huang M; Wu Y; Xuan J
    Clin Ther; 2019 Aug; 41(8):1440-1452. PubMed ID: 31155146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic inertia in patients treated with two or more antidiabetics in primary care: Factors predicting intensification of treatment.
    Mata-Cases M; Franch-Nadal J; Real J; Gratacòs M; López-Simarro F; Khunti K; Mauricio D
    Diabetes Obes Metab; 2018 Jan; 20(1):103-112. PubMed ID: 28656746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slow response to loss of glycemic control in type 2 diabetes mellitus.
    Brown JB; Nichols GA
    Am J Manag Care; 2003 Mar; 9(3):213-7. PubMed ID: 12643338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethnic disparities in initiation and intensification of diabetes treatment in adults with type 2 diabetes in the UK, 1990-2017: A cohort study.
    Mathur R; Farmer RE; Eastwood SV; Chaturvedi N; Douglas I; Smeeth L
    PLoS Med; 2020 May; 17(5):e1003106. PubMed ID: 32413037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes.
    Desai U; Kirson NY; Kim J; Khunti K; King S; Trieschman E; Hellstern M; Hunt PR; Mukherjee J
    Diabetes Care; 2018 Oct; 41(10):2096-2104. PubMed ID: 30131396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States.
    Ali SN; Dang-Tan T; Valentine WJ; Hansen BB
    Adv Ther; 2020 Feb; 37(2):869-882. PubMed ID: 31925649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin.
    Khunti K; Nikolajsen A; Thorsted BL; Andersen M; Davies MJ; Paul SK
    Diabetes Obes Metab; 2016 Apr; 18(4):401-9. PubMed ID: 26743666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Timely Treatment Intensification on Glycemic Goal Achievement in Patients With Type 2 Diabetes Failing Metformin Monotherapy.
    Mahabaleshwarkar R; Templin M; Gohs F; Mulder H; DeSantis A; Ejzykowicz F; Rajpathak S; Wilkins N
    Diabetes Educ; 2017 Oct; 43(5):495-505. PubMed ID: 28828933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
    Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
    Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidiabetic treatment patterns in a medicare advantage population in the United States.
    Slabaugh SL; Xu Y; Stacy JN; Baltz JC; Meah YA; Lian J; Moretz DC; Bouchard JR
    Drugs Aging; 2015 Feb; 32(2):169-78. PubMed ID: 25573537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of vildagliptin as add-on to metformin monotherapy among uncontrolled type 2 diabetes mellitus patients in a real-world setting.
    Melzer Cohen C; Davis C; Shalev V; Chodick G
    J Diabetes; 2018 Jan; 10(1):68-72. PubMed ID: 28418203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-World Adequacy of Glycaemic Control in Treatment-Naïve Greek Patients with Type 2 Diabetes Mellitus Initiating Treatment with Metformin Monotherapy at the Maximum Tolerated Dose: The Reload Study.
    Tsimihodimos V; Bargiota A; Pagkalos EM; Manes C; Papas A; Karamousouli E; Voss B; Elisaf MS
    Exp Clin Endocrinol Diabetes; 2020 Apr; 128(4):224-230. PubMed ID: 30669167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [INERTIA study: Clinical inertia in non-insulinized patients on oral hypoglycemic treatment. A study in Spanish primary and specialty care settings].
    González-Clemente JM; Font B; Lahoz R; Llauradó G; Gambús G;
    Med Clin (Barc); 2014 Jun; 142(11):478-84. PubMed ID: 23622897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.